Raffles Medical Group (BSL) Stock Statistics & Valuation Metrics

Raffles Medical Group has a market cap or net worth of SGD 1.59B. The enterprise value is SGD 1.46B.

Market Cap

SGD 1.59B

Enterprise Value

SGD 1.46B

Raffles Medical Group has 1,884,544,900 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

1,884,544,900

Owned by Insiders

58.34%

Owned by Institutions

4.07%

Raffles Medical Group’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 5.79%.

Return on Equity (ROE)

0.07

Return on Assets (ROA)

0.05

Return on Invested Capital (ROIC)

5.79%

Return on Capital Employed (ROCE)

0.08

Revenue Per Employee

263.90K

Profits Per Employee

24.33K

Employee Count

2,900

Asset Turnover

0.54

Inventory Turnover

55.81

The current PE Ratio of Raffles Medical Group is 23.22. Raffles Medical Group’s PEG ratio is 3.63.

PE Ratio

23.22

PS Ratio

2.11

PB Ratio

1.50

Price to FCF

15.45

Price to Operating Cash Flow

14.34

PEG Ratio

3.63

In the last 12 months, Raffles Medical Group had revenue of 765.30M and earned 70.57M in profits. Earnings per share was 0.04.

Revenue

765.30M

Gross Profit

136.74M

Operating Income

87.26M

Pretax Income

92.62M

Net Income

70.57M

EBITDA

131.82M

Earnings Per Share (EPS)

0.04

In the last 12 months, operating cash flow was 109.28M and capital expenditures -8.06M, giving a free cash flow of 101.22M billion.

Operating Cash Flow

109.28M

Free Cash Flow

101.22M

Free Cash Flow per Share

0.05

Raffles Medical Group pays an annual dividend of SGD 0.03, resulting in a dividend yield of 3.53%

Dividend Per Share

SGD 0.03

Dividend Yield

3.53%

Payout Ratio

73.53%

Free Cash Flow Yield

6.47%

Earnings Yield

4.31%

Beta

0.23

52-Week Price Change

-15.84%

50-Day Moving Average

0.83

200-Day Moving Average

0.92

Relative Strength Index (RSI)

63.41

Average Volume (3m)

2.80M

Raffles Medical Group upcoming earnings date is ―, After Close (Confirmed).

Last Earnings Date

Jul 26, 2026

Next Earnings Date

―

Ex-Dividend Date

May 13, 2025

Raffles Medical Group as a current ratio of 1.31, with Debt / Equity ratio of 8.26%

Current Ratio

1.31

Quick Ratio

1.27

Debt to Market Cap

0.04

Net Debt to EBITDA

-1.69

Interest Coverage Ratio

21.31

In the past 12 months, Raffles Medical Group has paid 21.55M in taxes.

Income Tax

21.55M

Effective Tax Rate

0.23

Raffles Medical Group EV to EBITDA ratio is 10.52, with an EV/FCF ratio of 13.20.

EV to Sales

1.80

EV to EBITDA

10.52

EV to Free Cash Flow

13.20

EV to Operating Cash Flow

12.23

Raffles Medical Group has SGD 262.30M in cash and marketable securities with SGD 34.18M in debt, giving a net cash position of SGD 228.12M billion.

Cash & Marketable Securities

SGD 262.30M

Total Debt

SGD 34.18M

Net Cash

SGD 228.12M

Net Cash Per Share

SGD 0.12

Tangible Book Value Per Share

SGD 0.56

Gross margin is 44.35%, with operating margin of 11.73%, and net profit margin of 9.12%.

Gross Margin

44.35%

Operating Margin

11.73%

Pretax Margin

12.00%

Net Profit Margin

9.12%

EBITDA Margin

17.15%

EBIT Margin

11.14%

The average price target for Raffles Medical Group is SGD 1.09, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target

SGD 1.09

Price Target Upside

28.24% Upside

Analyst Consensus

Moderate Buy

Analyst Count

1

Revenue Growth Forecast

-3.18%

EPS Growth Forecast

6.71%

Smart Score

4

AI Score

67